MoleculeMind

Founded in 2022, MoleculeMind operates at the intersection of AI, biology and engineering. Our scientific team has developed pioneering technologies, including our proprietary MoleculeOS® platform. These innovations enable us to overcome the limitations of natural proteins, delivering next-generation biologics—from therapeutic proteins to industrial enzymes—to address global challenges in healthcare and biomanufacturing